Recombinant Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)

FH3; HCHOLA3; NARC1; Hypercholesterolemia,Autosomal Dominant 3; Neural apoptosis-regulated convertase 1; Proprotein convertase 9; Subtilisin/kexin-like protease PC9

  • Recombinant Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Packages (Simulation)
  • Recombinant Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Packages (Simulation)
  • Recombinant Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Figure . Gene Sequencing (extract)
  • RPE189Ra01.jpg SDS-PAGE
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

SEQUENCE of the Recombinant Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)

USAGE of the Recombinant Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)

Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

STORAGE of the Recombinant Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

STABILITY of the Recombinant Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

GUESTBOOK